RAPT Therepeutics, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: San Francisco CA United States (2013)

Organization Overview

First Clinical Trial
2015
NCT02335814
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

FLX Bio | FLX Bio, Inc. | RAPT Therapeutics | RAPT Therapeutics, Inc. | RAPT Therepeutics, Inc.